Axsome Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $11M | 87k | 121.45 |
| 2025-06-30 | $14M | 134k | 104.39 |
| 2025-03-31 | $8.7M | 75k | 116.63 |
| 2024-12-31 | $4.9M | 58k | 84.61 |
| 2024-09-30 | $4.3M | 48k | 89.87 |
| 2024-06-30 | $4.5M | 56k | 80.50 |
| 2024-03-31 | $2.3M | 29k | 79.80 |
| 2023-12-31 | $2.4M | 30k | 79.59 |
| 2023-09-30 | $2.4M | 34k | 69.89 |
| 2023-06-30 | $1.5M | 25k | 61.68 |
| 2023-03-31 | $1.5M | 25k | 61.68 |
| 2022-12-31 | $2.1M | 27k | 77.13 |
| 2022-09-30 | $1.1M | 25k | 44.62 |
| 2022-06-30 | $845k | 22k | 38.30 |
| 2022-03-31 | $950k | 23k | 41.39 |
| 2021-12-31 | $867k | 23k | 37.78 |
| 2021-09-30 | $757k | 23k | 32.96 |
| 2021-06-30 | $1.9M | 28k | 67.46 |
| 2021-03-31 | $1.4M | 25k | 56.62 |
| 2020-12-31 | $2.0M | 28k | 71.25 |
| 2020-09-30 | $2.0M | 28k | 71.25 |
| 2020-06-30 | $2.2M | 27k | 82.28 |
| 2020-03-31 | $1.1M | 19k | 58.83 |
| 2019-12-31 | $2.4M | 23k | 103.36 |
| 2019-09-30 | $268k | 13k | 20.24 |
| 2019-06-30 | $598k | 23k | 25.75 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas